Tear; Knee, Cartilage, Articular Clinical Trial
Official title:
Matrix-encapsulated Arthroscopic Autologous Chondrocyte Implantation Versus Microfractures for Articular Cartilage Regeneration. Randomised Clinical Trial.
Verified date | April 2017 |
Source | Instituto Nacional de Rehabilitacion |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a phase III, randomised controlled trial of matrix-encapsulated chondrocyte implantation procedure compared to the microfracture procedure in the repair of symptomatic cartilage lesions of the knee. Eligible patients were asked for informed consent preoperatively and randomised for chondrocyte implantation of microfractures. Those patients allocated to the chondrocyte implantation group will be harvested at time of first arthroscopic procedure and concurrent lesions were treated, as meniscus repair, ligament reconstruction, or malalignment corrected. The patients allocated to microfracture will be treated at the time of the only arthroscopic procedure. Both groups will have the same rehabilitation program. Prospective clinical, radiographic and magnetic resonance imaging will be performed as main outcomes.
Status | Completed |
Enrollment | 48 |
Est. completion date | January 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Patients with symptomatic single chondral lesions of the knee from 1 to 4 cm2. - Signed patient informed consent. - Agree to adhere to rehabilitation protocol. Exclusion Criteria: - Inflammatory arthritis, septic arthritis, gout, pseudogout, Paget's disease, ochronosis, acromegaly, hemochromatosis, tumors, collagen mutations. - Total meniscectomy - Malalignment - Evidence of osteoarthritis |
Country | Name | City | State |
---|---|---|---|
Mexico | National Institute of Rehabilitation | Mexico City |
Lead Sponsor | Collaborator |
---|---|
Instituto Nacional de Rehabilitacion | National Council of Science and Technology, Mexico |
Mexico,
Ibarra C, Izaguirre A, Villalobos E, Masri M, Lombardero G, Martinez V, Velasquillo C, Meza AO, Guevara V, Ibarra LG. Follow-up of a new arthroscopic technique for implantation of matrix-encapsulated autologous chondrocytes in the knee. Arthroscopy. 2014 Jun;30(6):715-23. doi: 10.1016/j.arthro.2014.02.032. Epub 2014 Apr 18. — View Citation
Ibarra-Ponce de León JC, Velasquillo-Martínez MC, Izaguirre A, Villalobos-Córdova E, Masri M, Ibarra-Ibarra LG. [Cartilage repair: cell-based techniques]. Acta Ortop Mex. 2009 Jan-Feb;23(1):38-44. Review. Spanish. — View Citation
Masri M, Lombardero G, Velasquillo C, Martínez V, Neri R, Villegas H, Ibarra C. Matrix-encapsulation cell-seeding technique to prevent cell detachment during arthroscopic implantation of matrix-induced autologous chondrocytes. Arthroscopy. 2007 Aug;23(8):877-83. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | MRI T2 Mapping | Special magnetic resonance imaging technique for measurement of collagen and water content, expressed in milliseconds. | 24 months | |
Secondary | Clinical evaluation | Clinical assessment with validated knee scores, and adverse effects register are taken. | 0, 10, 30 days; 3, 6, 9 ,12, 24, 36 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02673905 -
Clinical Trial for the Regeneration of Cartilage Lesions in the Knee
|
N/A | |
Completed |
NCT01503970 -
Autologous Chondrocyte Transplantation For Articular Cartilage Regeneration
|
Phase 1/Phase 2 |